C - Chemistry – Metallurgy – 12 – N
Patent
C - Chemistry, Metallurgy
12
N
167/37, 195/1.10
C12N 15/28 (2006.01) A61K 38/19 (2006.01) A61K 39/395 (2006.01) C07K 14/47 (2006.01) C07K 14/525 (2006.01) C07K 14/715 (2006.01) C07K 16/18 (2006.01) C07K 16/24 (2006.01) C07K 16/28 (2006.01) C12N 1/21 (2006.01) G01N 33/53 (2006.01) A61K 38/00 (2006.01)
Patent
CA 2017025
Tumor Necrosis Factor (TNF) Binding Protein is isolated and substantially purified. It has the ability to inhibit the cytotoxic effect of TNF and/or to maintain its prolonged beneficial effects. TNF Binding Protein II and salts, functional derivative, precursors and active fractions thereof can be used to antagonize the deleterious effects of TNF and to prolong its beneficial effects. Polyclonal and monoclonal antibodies to the TNF Binding Protein II are produced. They may be used as pharmaceutical agents and in diagnostic assays.
Aderka Dan
Engelmann Hartmut
Novick Daniela
Rubinstein Menachem
Wallach David
Aderka Dan
Borden Ladner Gervais Llp
Engelmann Hartmut
Novick Daniela
Rubinstein Menachem
LandOfFree
Tumor necrosis factor binding protein ii, its purification... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Tumor necrosis factor binding protein ii, its purification..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Tumor necrosis factor binding protein ii, its purification... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1822089